A股貝達藥業(深:300558)已通過聯交所上市聆訊,市場消息指,貝達藥業計劃集資多達10億美元(約77.5億港元),高盛、瑞銀及中金為聯席保薦人。貝達藥業指,集資所得的資金計劃用於未來5年在中國及海
【新股IPO】貝達藥業通過上市聆訊 集資達78億元、估值高達727億元 – 香港經濟日報 – 即時新聞頻道 – 即市財經 – 新股IPO
2021-05-31T07:06:00-04:00May 31st, 2021|
Related Posts
-
US seeks 3 years imprisonment for Binance founder Zhao
April 24th, 2024 -
Bahrain’s Investcorp sets up $1b fund backed by China’s CIC
April 24th, 2024 -
Hong Kong bourse names Carlson Tong as its new chairman
April 24th, 2024